TransMedics Group, Inc. Company Profile & Data: stocks, market cap, financials, digital and more

                        
Company
TransMedics Group, Inc.Headquarters: Andover, 
                        MA, United States
                    
Employees: 148
CEO: Dr. Waleed H. Hassanein

                                    NASDAQ: TMDX
                                
                                            -4.64%
                                            
Market Cap$2.10 Billion

                        USD as of Jan. 1, 2025
                    
                            Market Cap History

TransMedics Group, Inc. Categories

United States Healthcare Medical Devices
United States Healthcare United States Medical Devices

TransMedics Group, Inc. market capitalization over time

Evolution of TransMedics Group, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of TransMedics Group, Inc.

Top Competitors by Market Capitalization

Industry: Medical Devices

Company	Market Cap (USD)
Abbott	$213.72 B
Stryker	$150.01 B
Boston Scientific Corporation	$149.80 B
Medtronic	$114.44 B
Shenzhen Mindray Bio-Medical Electronics Co. Ltd	$47.37 B

Sector:

Company	Market Cap (USD)
Lilly	$689.42 B
Novo Nordisk	$622.07 B
UnitedHealth Group	$487.54 B
Johnson & Johnson	$353.05 B
AbbVie	$301.60 B

Detailed Description

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Tweets by TransMedics Group, Inc.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Financials

Last Financial Reports Date	Sept. 30, 2024
Revenue TTM	$401.1 M
EBITDA	$64.3 M
Gross Profit TTM	$238.0 M
Profit Margin	8.14%
Operating Margin	3.61%
Quarterly Revenue Growth	63.70%